Rankings
▼
Calendar
LUNG Q2 2025 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena
LUNG
Pulmonx Corporation
$75M
Q2 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$24M
+14.8% YoY
Gross Profit
$17M
72.1% margin
Operating Income
-$15M
-62.0% margin
Net Income
-$15M
-63.6% margin
EPS (Diluted)
$-0.38
QoQ Revenue Growth
+5.9%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$147M
Total Liabilities
$78M
Stockholders' Equity
$69M
Cash & Equivalents
$75M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$21M
+14.8%
Gross Profit
$17M
$15M
+12.4%
Operating Income
-$15M
-$16M
+5.2%
Net Income
-$15M
-$15M
+1.0%
Geographic Segments
UNITED STATES
$15M
62%
EMEA
$7M
29%
Asia Pacific
$2M
8%
Other International Geographical Areas
$102,000
0%
← FY 2025
All Quarters
Q3 2025 →